Variable dystrophin expression in different muscles of a Duchenne muscular dystrophy carrier
- PMID: 1355417
- DOI: 10.1111/j.1399-0004.1992.tb03133.x
Variable dystrophin expression in different muscles of a Duchenne muscular dystrophy carrier
Abstract
The majority of Duchenne muscular dystrophy (DMD) female carriers show dystrophin immunostaining abnormalities, although a significant proportion of clinically non-manifesting carriers are normal following this analysis. We had the opportunity to study dystrophin immunostaining in two different muscles, the vastus lateralis and the rectus abdominis of a possible DMD carrier. While the vastus showed normal dystrophin immunostaining, pathological staining was detected in her rectus abdominis. These findings seem to indicate that dystrophin expression can vary in different muscle groups of a DMD carrier. The implications of these findings in DMD carrier detection and possible dystrophin function are discussed.
Similar articles
-
Reciprocal expression of dystrophin and utrophin in muscles of Duchenne muscular dystrophy patients, female DMD-carriers and control subjects.J Neurol Sci. 1993 Oct;119(1):43-52. doi: 10.1016/0022-510x(93)90190-a. J Neurol Sci. 1993. PMID: 8246010
-
Dystrophin immunohistochemistry in a symptomatic carrier of Becker muscular dystrophy.J Neurol. 1991 Oct;238(7):375-8. doi: 10.1007/BF00319855. J Neurol. 1991. PMID: 1683669
-
Dystrophin protein and RFLP analysis for fetal diagnosis and carrier confirmation of Duchenne muscular dystrophy.Prenat Diagn. 1990 Nov;10(11):703-15. doi: 10.1002/pd.1970101104. Prenat Diagn. 1990. PMID: 1980950
-
A carrier of Duchenne muscular dystrophy with dilated cardiomyopathy but no skeletal muscle symptom.Brain Dev. 1995 May-Jun;17(3):202-5. doi: 10.1016/0387-7604(95)00018-7. Brain Dev. 1995. PMID: 7573761 Review.
-
Dystrophin abnormality in progressive muscular dystrophy--a review article.Acta Paediatr Jpn. 1991 Apr;33(2):216-21. doi: 10.1111/j.1442-200x.1991.tb01546.x. Acta Paediatr Jpn. 1991. PMID: 1957648 Review.
Cited by
-
Integrated study of 100 patients with Xp21 linked muscular dystrophy using clinical, genetic, immunochemical, and histopathological data. Part 3. Differential diagnosis and prognosis.J Med Genet. 1993 Sep;30(9):745-51. doi: 10.1136/jmg.30.9.745. J Med Genet. 1993. PMID: 8411069 Free PMC article.
-
DMD carrier model with mosaic dystrophin expression in the heart reveals complex vulnerability to myocardial injury.Hum Mol Genet. 2020 Apr 15;29(6):944-954. doi: 10.1093/hmg/ddaa015. Hum Mol Genet. 2020. PMID: 31976522 Free PMC article.
-
Clinical and genetic characterization of manifesting carriers of DMD mutations.Neuromuscul Disord. 2010 Aug;20(8):499-504. doi: 10.1016/j.nmd.2010.05.010. Epub 2010 Jul 13. Neuromuscul Disord. 2010. PMID: 20630757 Free PMC article.
-
Genetic characterization in symptomatic female DMD carriers: lack of relationship between X-inactivation, transcriptional DMD allele balancing and phenotype.BMC Med Genet. 2012 Aug 16;13:73. doi: 10.1186/1471-2350-13-73. BMC Med Genet. 2012. PMID: 22894145 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical